An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Tumour-infiltrating lymphocytes are associated with a survival benefit in several tumour types and with the response to immunotherapy . However, the reason some tumours have high CD8 T cell infiltration while others do not remains unclear. Here we investigate the requirements for maintaining a CD8 T...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 576; no. 7787; pp. 465 - 470
Main Authors Jansen, Caroline S, Prokhnevska, Nataliya, Master, Viraj A, Sanda, Martin G, Carlisle, Jennifer W, Bilen, Mehmet Asim, Cardenas, Maria, Wilkinson, Scott, Lake, Ross, Sowalsky, Adam G, Valanparambil, Rajesh M, Hudson, William H, McGuire, Donald, Melnick, Kevin, Khan, Amir I, Kim, Kyu, Chang, Yun Min, Kim, Alice, Filson, Christopher P, Alemozaffar, Mehrdad, Osunkoya, Adeboye O, Mullane, Patrick, Ellis, Carla, Akondy, Rama, Im, Se Jin, Kamphorst, Alice O, Reyes, Adriana, Liu, Yuan, Kissick, Haydn
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Tumour-infiltrating lymphocytes are associated with a survival benefit in several tumour types and with the response to immunotherapy . However, the reason some tumours have high CD8 T cell infiltration while others do not remains unclear. Here we investigate the requirements for maintaining a CD8 T cell response against human cancer. We find that CD8 T cells within tumours consist of distinct populations of terminally differentiated and stem-like cells. On proliferation, stem-like CD8 T cells give rise to more terminally differentiated, effector-molecule-expressing daughter cells. For many T cells to infiltrate the tumour, it is critical that this effector differentiation process occur. In addition, we show that these stem-like T cells reside in dense antigen-presenting-cell niches within the tumour, and that tumours that fail to form these structures are not extensively infiltrated by T cells. Patients with progressive disease lack these immune niches, suggesting that niche breakdown may be a key mechanism of immune escape.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions C.S.J. and H.K. conceived and designed the study and composed the manuscript. C.S.J., V.A.M., M.G.S., C.P.F., M.A. and H.K. designed experiments. C.S.J., N.P., J.W.C., M.C., R.M.V., W.H.H., D.M., K.M., A.I.K., K.K., Y.M.C., A.K., A.O.K., A.R. and H.K. collected flow cytometry data. C.S.J., N.P., M.C. and H.K. analysed flow cytometry data. C.S.J., N.P., M.C., A.R. and H.K. performed fluorescence activated cell sorting. C.S.J., N.P. and M.C. performed RNA and DNA extractions. C.S.J., S.W., R.L. and A.G.S. optimized and performed immunofluorescence slide scanning. C.S.J. and H.K. developed quantitative immunofluorescence techniques and performed quantitative analysis of immunofluorescence data. W.H.H., D.M. and H.K. performed RNA sequencing analysis. N.P., M.C., K.K., Y.M.C., A.K. and H.K. performed in vitro T cell assays. N.P. and H.K. performed whole-genome methylation analysis. R.A., S.J.I. and A.O.K. provided critical expertise and contributed specific analysis. V.A.M., M.G.S., C.P.F. and M.A. provided clinical samples. C.S.J., J.W.C. and A.R. collected and organized clinical data. K.M., A.O.O., P.M. and C.E. provided annotation and scoring of pathology specimen. Y.L. assisted with biostatistical analysis. All authors reviewed the manuscript.
ISSN:0028-0836
1476-4687
DOI:10.1038/s41586-019-1836-5